Complex Percutaneous Coronary Intervention

This thesis contains 17 chapters about two major subjects. Part I focuses on the effects of chronic total occlusion percutaneous coronary intervention (CTO PCI) on myocardial ischemia reduction measured by [15O]H2O positron emission tomography (PET)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4612::561532a2552927c4434efbafa817d5e6
https://doi.org/10.5463/thesis.24

18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation

Conclusion This thesis evaluated the role of [18F]FDG PET as a biomarker in aggressive lymphoma by both technical and clinical validation. It can be concluded that the role of [18F]FDG PET in treating aggressive lymphoma patients has clearly grown in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4612::5dfeac890a6e96a5a0bbf32e40779e88
https://research.vu.nl/en/publications/c50b2f47-5cc3-43e4-8584-e3a1923912aa

Advances in coronary CT angiography and PET perfusion imaging for the detection of coronary artery disease

Autor: Bom, MJ

Publikováno v: Bom, M J 2022, ' Advances in coronary CT angiography and PET perfusion imaging for the detection of coronary artery disease ', Dr., Vrije Universiteit Amsterdam .
Bom, MJ 2022, ' Advances in coronary CT angiography and PET perfusion imaging for the detection of coronary artery disease ', Doctor of Philosophy, Vrije Universiteit . < https://research.vu.nl/en/publications/advances-in-coronary-ct-angiography-and-pet-perfusion-imaging-for >

The diagnostic work-up of patients with suspected CAD involves a clinical evaluation estimating the probability of disease followed by a non-invasive imaging test. A myriad of non-invasive imaging modalities are available for this purpose and can be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c9dd6a72a9721e26e9726b9cd10d63ad
https://hdl.handle.net/1871.1/f00c767c-2bd0-4c4f-ae40-8659e1fb67f4

Discordance between amyloid-β PET and CSF biomarkers:Clinical and pathophysiological consequences

Autor: Reimand, Juhan

Publikováno v: Reimand, J 2021, ' Discordance between amyloid-β PET and CSF biomarkers : Clinical and pathophysiological consequences ', PhD, Vrije Universiteit Amsterdam, Amsterdam .
Reimand, J 2021, ' Discordance between amyloid-β PET and CSF biomarkers : Clinical and pathophysiological consequences ', Doctor of Philosophy, Vrije Universiteit Amsterdam, Amsterdam . < https://hdl.handle.net/1871.1/0c7c540a-48e8-47b0-be3d-4cc530fa799c >

Among the earliest neuropathological events in Alzheimer’s disease (AD) is the accumulation and aggregation of amyloid-β, which occurs decades before symptom onset. Two methods, amyloid-β positron emission tomography (PET) and Aβ42 levels in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8d78575f37f786590eb08e3605367e1b
https://research.vu.nl/en/publications/0c7c540a-48e8-47b0-be3d-4cc530fa799c

Discordance between amyloid-β PET and CSF biomarkers

Among the earliest neuropathological events in Alzheimer’s disease (AD) is the accumulation and aggregation of amyloid-β, which occurs decades before symptom onset. Two methods, amyloid-β positron emission tomography (PET) and Aβ42 levels in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4612::d881e88c7b83be4d5a6e7ad2eb292e4f
https://research.vu.nl/en/publications/0c7c540a-48e8-47b0-be3d-4cc530fa799c